Regressive effect of intralesional injection of a moderate dose of recombinant interleukin-2 on carcinoma erysipeloides from gastric carcinoma

Clinical and Experimental Dermatology

Volumn 26, Issue 1, 2001, Pages 42-44

  Hamamoto, Y ^a   Nagai, K ^a   Ichimiya, M ^a   Yamamoto, K ^a   Kinoshita, E ^a   Muto, M ^a,b  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT INTERLEUKIN 2;

AGED; ARTICLE; CASE REPORT; GASTRECTOMY; HUMAN; MALE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN METASTASIS; STOMACH CARCINOMA;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS; BIOPSY; FATAL OUTCOME; HUMANS; INJECTIONS, INTRALESIONAL; INTERLEUKIN-2; MALE; RECOMBINANT PROTEINS; SKIN NEOPLASMS; STOMACH NEOPLASMS;

EID: 0035095229     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2001.00758.x     Document Type: Article

References (6)

1. Differential responses to chemoimmunotherapy in patients with metastatic malignant melanoma
2. Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8 (+) selected tumor infiltrating lymphocytes from primary tumor
3. A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remission
4. A spectrum of inflammatory metastasis to skin via lympatics: Three cases of carcinoma erysipeloides
5. Cutaneous metastasis
6. Natural history and therapy of metastatic renal cell carcinoma: The role of interleukin-2